Here we describe the proteomic identification of the novel cell surface antigen SAIL (Surface Antigen In Leukemia) and the preclinical characterization of ADCs with potent in vitro and in vivo activity against SAIL-expressing hematologic tumors. The gene discussed is C16orf54; the disease is hematopoietic and lymphoid cell neoplasm.